Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration.

@article{Asten2013PredictingNT,
  title={Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration.},
  author={Freekje van Asten and Maroeska M Rovers and Yara T. E. Lechanteur and D{\vz}enita Smailhodzic and Philipp Sebastian Muether and John Chen and Anneke I. den Hollander and Sascha Fauser and Carel B. Hoyng and Gert Jan van der Wilt and B Jeroen Klevering},
  journal={Ophthalmic epidemiology},
  year={2013},
  volume={21 6},
  pages={
          347-55
        }
}
  • Freekje van Asten, Maroeska M Rovers, +8 authors B Jeroen Klevering
  • Published in Ophthalmic epidemiology 2013
  • Medicine, Biology
  • PURPOSE To validate known and determine new predictors of non-response to ranibizumab in patients with neovascular age-related macular degeneration (AMD) and to incorporate these factors into a prediction rule. METHODS This multicenter, observational cohort study included 391 patients treated with ranibizumab for neovascular AMD. We performed genetic analysis for single nucleotide polymorphisms in AMD-associated genes and collected questionnaires regarding environmental factors and disease… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 17 CITATIONS